Raymond James Financial
ETON icon

Raymond James Financial’s Eton Pharmaceutcials ETON Stock Holding History

Raymond James Financial’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$450K Buy
12,444
+194
+2% +$5.69K ﹤0.01% 4590
2026
Q1 		$302K Hold
12,250
– – ﹤0.01% 4651
2025
Q4 		$207K Sell
12,250
-74,832
-86% -$1.32M ﹤0.01% 4773
2025
Q3 		$1.89M Sell
87,082
-3,333
-4% -$55.3K ﹤0.01% 3214
2025
Q2 		$1.29M Buy
90,415
+12,202
+16% +$193K ﹤0.01% 3403
2025
Q1 		$1.02M Buy
78,213
+67,170
+608% +$1.01M ﹤0.01% 3481
2024
Q4 		$147K Buy
+11,043
New +$112K ﹤0.01% 4470

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Raymond James Financial's ETON Position: Q2 2026 in Review

Raymond James Financial increased its Eton Pharmaceutcials (ETON) stake by 1.6% in Q2 2026, buying an estimated $5.69K and bringing the position to 12,444 shares worth $450K. The position accounts for ﹤0.01% of the portfolio, ranked #4590.

Raymond James Financial first reported a position in ETON in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.89M in Q3 2025. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Raymond James Financial held 12,444 shares of Eton Pharmaceutcials worth $450K as of Q2 2026.
  • Raymond James Financial bought 194 Eton Pharmaceutcials shares in Q2 2026, an estimated $5.69K.
  • Eton Pharmaceutcials made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4590 holding.
  • Raymond James Financial first reported a position in Eton Pharmaceutcials in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Eton Pharmaceutcials position peaked at $1.89M in Q3 2025.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.